- Charles Krauthammer on the Price of Modernity In the midst of public outrage over Toyota's accelerator crisis, the Washington Post columnist argues
the recall is just the latest price of living in a society of
state-of-the-art, mass-produced products. Comparing the Toyota furor to
the recall of the prescription drug Vioxx, Krauthammer argues we need
to accept the reality of the situation.
"But it is no disrespect
to the memory of those killed, and the sorrow of those left behind, to
simply admit that even the highest technology produced by the world's
finest companies can be fallible and fatal, and that the intelligent
response is not rage and retribution but sober remediation and
recognition of the very high price we pay -- willingly pay -- for
modernity with all its wondrous, dangerous bounty."
- David Brooks on the Health Care Summit The New York Times columnist comes away
from the debate pleasantly surprised and cautiously optimistic. Though
he thinks the bell has tolled for the current reform effort, Brooks
sees hope for the next set of would-be reformers. "Health care reform
probably will not get passed this year. But there were moments, at the
most wonky and specific, when the two sides echoed each other. Glimmers
of hope for the next set of reformers."
- Thomas Penfield Jackson on Bringing KSM to D.C. A retired judge from the D.C. district court, Jackson confesses in The Washington Post that he has "difficulty appreciating" New York's resistance to holding the trial of alleged 9/11 plotter Khalid Sheikh Mohammed. His solution: bring KSM to D.C. He reasons that because KSM's crimes were committed against the whole U.S., "it is fitting that the nation's capital should host his trial." Then reflecting on his "generally favorable" experience with D.C. juries, he concludes "there is virtually no possibility of an acquittal."
Want to add to this story? Let us know in comments
or send an email to the author at
bcarlson at theatlantic dot com or .
You can share ideas for stories on the Open Wire.